A variety of dietary and metabolic factors may contribute or cause stone formation in idiopathic calcium oxalate nephrolithiasis. Dietary factors include a high intake of animal proteins, oxalate and sodium, and a low intake of fluids and potassium-containing citrus products. Some of the metabolic causes of stones are hypercalciuria, hypocitraturia, gouty diathesis, hyperoxaluria, and hyperuricosuria. Dietary modification, to be applied in all patients with stones includes a high fluid intake, restriction of oxalate and sodium, and balanced diet with animal proteins complemented by adequate intake of fruits and vegetables. When dietary modification is ineffective in controlling stone formation or in the presence of severe metabolic derangements, a pharmacologic intervention may be necessary. In a simple approach, thiazide or indapamide with potassium citrate is recommended for patients with hypercalciuria, and potassium citrate alone for the remaining normocalciuric subjects.

Keywords:
Diet, Kidney stones
1.
Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R: The effect of high dietary protein intake on the risk of calcium stone formation in the urinary tract. Clin Sci 1979;57:285–288.
2.
Hess B, Ackerman D, Essig M, Takkinen R, Jaeger P: Renal mass and serum calcitriol in male idiopathic calcium stone former: Role of animal proteins. J Clin Endo Metab 1995;80:1916–1921.
3.
Wabner CL, Pak CY: Effect of orange juice consumption on urinary stone risk factors. J Urol 1993;149:1405–1408.
4.
Reddy ST, Wang CY, Sakhaee K, Pak CY: Effect of low carbohydrate, high protein diet diets on acid-base balance, stone-forming propensity and calcium metabolism. Am J Kid Dis 2002;40:265–274.
5.
Coe FL, Moran E, Kavalich A: The contribution of dietary purine over-consumption to hyperuricosuria in calcium oxalate stone-formers. J Chron Dis 1976;29:793–800.
6.
Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P: High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dialy Transplant 1998;13:2241–2247.
7.
Sakhaee K, Baker S, Zerwekh J, Poindexter J, Garcia-Hernandez PA, Pak CY: The limited risk of kidney stone formation during long-term calcium citrate supplementation in non-stone-forming subjects. J Urol 1994;152:324–327.
8.
Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CY: Effect of dietary calcium on stone-forming propensity. J Urol 2003;161:2325–2333.
9.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833–838.
10.
Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lemke M, Padalino P, Pak CY: Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 2002;87:1476–1485.
11.
Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH: Biochemical profile of patients with idiopathic uric acid nephrolithiasis. Kidney Int 2001;60:757–761.
12.
Gianfrancesco F, Esposito T, Ombra MN, Forabosco P, Maninchedda G, Fattorini M, Casula S, Vaccargiu S, Casu G, Cardia F, Deiana I, Melis P, Falchi M, Pirastu M: Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet 2003;72:1479–1491.
13.
Sakhaee K, Adams-Huet B, Moe OW, Pak CY: Pathophysiologic basis of normouricosuric uric acid nephrolithiasis. Kidney Int 2002;62:971–979.
14.
Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Gianni A: Urine volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective trial. J Urol 1996;155:839–843.
15.
Borghi L, Meschi T, Guerra A, Novarini A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrence. J Cardiovasc Pharm 1993;22:S78–S86.
16.
Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD: Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary-pharmacological interventions. J Urol 2003;169:465–469.
17.
Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761–1764.
18.
Ettinger B, Tang A, Citron CT, Livermore B, Williams T: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315:1386–1389.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.